Production of advanced drugs, increasing adoption of monoclonal antibodies, and clinical urgency to develop new generation immunomodulators are key factors contributing to the high CAGR of the Immunomodulators market during the forecast period. According to the current analysis of Reports and Data, the global Immunomodulators market was valued at USD 165.21 Billion in...